Physiological role of corticotropin-releasing factor in the control of adrenocorticotropin-mediated corticosterone release from the rat adrenal gland.
Marked fluctuations in adrenal sensitivity to ACTH have been reported under both physiological (e.g. diurnal) and experimental conditions. Recently, we reported that immunoneutralization of CRF reduces resting corticosterone (cort) levels in rats without inducing concomitant reductions in plasma ACTH. We postulated an endogenous CRF mechanism that controls the adrenal sensitivity to ACTH. In the present study, this hypothesis was tested by iv infusion of human ACTH (0, 1, 3, and 10 ng/kg.min for 60 min) into dexamethasone-treated anaesthetized male Wistar rats. Serial blood samples were taken for the determination of ACTH and corticosterone by RIA (ACTHi, corti). Infusion of ACTH resulted in dose-dependent steady state plasma ACTHi levels, ranging from 50-600 pg/ml, which were not affected by prior administration of a rat monoclonal antibody to rat CRF (PFU 83). As expected, infusion of ACTH resulted in a dose-dependent increase in plasma corti. In PFU 83-treated rats, preinfusion plasma corti levels were reduced compared to those of rat immunoglobulin G-treated controls (7.8 +/- 1.2 vs 25.3 +/- 3.2 ng/ml). In addition, the corti responses to infusion of 1 and 3 ng/kg.min ACTH were suppressed by PFU 83. However, at a (near) maximally effective dose of ACTH (10 ng/kg.min), no differences in plasma corti were found between PFU 83 and immunoglobulin G-treated rats. These findings suggest that immunoneutralization of endogenous CRF results in a 3-fold reduction of the adrenal sensitivity to ACTH. Subsequently, we studied the possible effects of exogenous CRF on the isolated perfused adrenal gland in situ. In this preparation, CRF alone (1-100 pmol) or ACTH alone (5 fmol) did not affect the corti secretion rate or the flow rate of the perfusion medium through the gland. However, when given together a marked (up to 3.2 times) CRF dose-dependent stimulation of corti secretion and an increase (up to 1.7 times) in adrenal flow rate were obtained. In experiments with freshly dispersed adrenal cells in vitro, PFU 83 (1 microM) or CRF (0.1-10 nM) did not influence corti secretion when given alone and did not affect ACTH-induced corti secretion. It is unlikely, therefore, that CRF acts directly on the steroid-producing cells.(ABSTRACT TRUNCATED AT 400 WORDS)
van Oers
J W
JW
Department of Pharmacology, Medical Faculty, Free University, Amsterdam, The Netherlands.
Hinson
J P
JP
Binnekade
R
R
Tilders
F J
FJ
D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology / Q000502:physiology*; D000818:Animals; D003345:Corticosterone / Q000378:metabolism*; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D066298:In Vitro Techniques; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains
D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D003345:Corticosterone